Marrone Bio Innovations: Bio-Based Plant Health Solutions Company joins hands with GBAL for BAW 2021
Updated: Nov 7
Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world. It works towards the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI is a leader in research and development and has screened over 18,000 microorganisms and 350 plant extracts. Leveraging on its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry it has developed seven product lines. MBI has over 400 issued and pending patents to its credit.
MBI’s robust portfolio includes various products such as Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™, Zelto® Jet Oxide® Jet Ag®, and Zequanox®. It has a next-generation insecticide-nematicide as well as a breakthrough bioherbicide and a biofumigant in the product pipeline. MBI’s Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality.
MBI being a leader in innovative and sustainable agriculture products believes that future agriculture will be different from the present and requires paradigm shift in the inputs. MBI has come together with GBAL to make BAW a greater success. With MBI on board we are hopeful to come up with strong strategic blue print for the agri-input industry to fulfill the needs of future agriculture.
To learn more about Marrone Bio Innovations visit www.marronebio.com or https://investors.marronebio.com (investor relations website) You may also follow MBI on social media: Twitter, LinkedIn and Instagram.